Workflow
中欧资源精选混合发起C
icon
Search documents
基金回报榜:190只基金昨日回报超5%
Group 1 - The core viewpoint of the articles highlights the performance of stock and mixed funds, with 82.12% achieving positive returns on October 9, 2023, and 190 funds reporting returns exceeding 5% [1][2] - The Shanghai Composite Index rose by 1.32% to close at 3933.97 points, while the Shenzhen Component Index increased by 1.47%, and the ChiNext Index rose by 0.73% [1] - The top-performing sectors included non-ferrous metals, steel, and coal, with respective increases of 7.60%, 3.38%, and 3.00% [1] Group 2 - Among the funds with a net value growth rate exceeding 5%, 92 were index stock funds, 68 were equity funds, and 16 were standard stock funds [2] - The fund with the highest net value growth rate was the China Europe Resource Selection Mixed Fund A, which achieved a growth rate of 9.85% [2] - The funds with the largest net value drawdown included the AVIC Optimal Navigation Mixed Fund C, which saw a decline of 4.79% [2][5] Group 3 - The average net value growth rate for stock and mixed funds on October 9 was 0.89% [1] - The top funds by net value growth rate included several from China Europe Fund and Qianhai Kaiyuan Fund, with growth rates ranging from 8.50% to 9.85% [2][3] - The funds with the most significant drawdowns were primarily from Changcheng Fund and AVIC Fund, with declines between 3.35% and 4.79% [5][6]
10/9财经夜宵:得知基金净值排名及选基策略,赶紧告知大家
Sou Hu Cai Jing· 2025-10-09 16:07
Core Insights - The article provides an overview of the performance of various mutual funds, highlighting the top and bottom performers based on net asset value updates as of October 9, 2025 [3][4]. Fund Performance Summary - The top 10 funds with the highest net value growth include: 1. China Europe Resource Selection Mixed Fund A (1.7106) 2. China Europe Resource Selection Mixed Fund B (1.7097) 3. Qianhai Kaiyuan Core Resource Mixed Fund C (5.1280) 4. Qianhai Kaiyuan Core Resource Mixed Fund A (5.1800) 5. Gold Stock ETF (2.1608) 6. Wanjia Cycle Vision Stock Fund A (1.1811) 7. Wanjia Cycle Vision Stock Fund C (1.1807) 8. Great Wall Value Selection One-Year Holding Mixed Fund A (1.3218) 9. Guotai Zhongzheng Gold Industry Stock ETF (1.7048) 10. Great Wall Value Selection One-Year Holding Mixed Fund C (1.2854) [3][4]. - The bottom 10 funds with the lowest net value growth include: 1. AVIC Preferred Navigation Mixed Fund C (1.8724) 2. AVIC Preferred Navigation Mixed Fund A (1.8814) 3. Great Wall Health Mixed Fund C (0.9919) 4. Great Wall Health Mixed Fund A (1.0224) 5. Great Wall Pharmaceutical Technology Six-Month Mixed Fund C (0.8284) 6. Great Wall Pharmaceutical Technology Six-Month Mixed Fund A (0.8466) 7. Ping An Hong Kong Stock Medical Innovation Selected Mixed Fund A (1.1783) 8. Ping An Hong Kong Stock Medical Innovation Selected Mixed Fund C (1.1767) 9. Yinhua Growth Smart Selected Mixed Fund C (1.0853) 10. Yinhua Growth Smart Selected Mixed Fund A (1.0871) [4]. Market Analysis - The Shanghai Composite Index opened high and showed a strong upward trend, while the ChiNext Index experienced a slight pullback. The total trading volume reached 2.67 trillion yuan, with a stock rise-to-fall ratio of 3115:2186 [6]. - The leading sectors included non-ferrous metals and mineral products, both showing gains exceeding 4%, while tourism, hotel catering, and media entertainment sectors faced declines of over 2% [6]. Fund Holdings Overview - The top holdings of the China Europe Resource Selection Mixed Fund include: 1. Zijin Mining (9.99% daily increase, 10.72% of net assets) 2. China Hongqiao (9.46% of net assets) 3. Shandong Gold (8.07% of net assets) 4. China Rare Earth (9.97% daily increase, 6.15% of net assets) 5. China Aluminum (6.00% of net assets) - The fund's top ten holdings account for 64.29% of total holdings, indicating a focus on resource industries [7]. - The top holdings of the AVIC Preferred Navigation Mixed Fund include: 1. Yiqi Hong (12.14% of net assets) 2. Rongchang Bio (11.63% of net assets) 3. Rejing Bio (11.33% of net assets) - The fund's top ten holdings account for 95.17% of total holdings, reflecting a clear focus on the pharmaceutical industry [7].